Beyond IGF-1R: IL-6R Inhibition and Future Sequencing
Prem S. Subramanian, MD, PhD
Kimberly Cockerham, MD
Why Staging TED Correctly Matters Even When CAS Is Low
Andrea Lora Kossler, MD, FACS
Overcoming Real-World Barriers to TED Treatment
Severity Matters: Aligning Thyroid Eye Disease Assessment With Modern Therapeutic Advances
Comparing Trial Designs & Outcomes Across IGF-1R Therapies
Applying CAS, EUGOGO, VISA: A Micro Case
Designing Efficient Clinic Workflows for TED Therapy Access
Understanding IGF-1R Inhibition: Mechanism & Clinical Implications
Why QoL Measures Change TED Management
Emerging Focus in NAION: Sharpening Diagnostic Precision for Tomorrow’s Treatments
Andrew G. Lee, MD
Valerie Biousse, MD
Patient at High Risk of Loss to Follow-Up, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
Deepak Sambhara, MD
It Takes a Village, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
David Eichenbaum, MD
Overcoming Cultural and Communication Disconnects, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
David Chin Yee, MD, FASRS
A Case of Missed Diagnosis, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
Esther Lee Kim, MD
Insights and Updates: New Data on Next-Generation Retinal Treatments
Durga Borkar, MD, MMCi
Veeral Sheth, MD, MBA, FASRS, FACS
Retina Case Review: Translating the Data Into Care
Loading...
We're glad to see you're enjoying Eye Health Academy… but how about a more personalized experience?
Press cancel to remain on Eye Health Academy. Press the link below or the continue button to keep going.